Third, regarding the ability of VEGF-C to discriminate between early ovarian cancer and benign diseases, less common histological types, and cases where CA125 is low, we need recruit more clinical cases and make an analysis of difference in depth. This evidence concerns the gene VEGFC and ovarian cancer.